Theriva Biologics, Inc.
TOVX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000894158
No open-market purchases or sales by Theriva Biologics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $495.5K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Theriva Biologics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −7 vs. Q2 2022
- Shares held
- 1.16M
- −17.1K (−1.4%) vs. Q2 2022Converted for a 1-for-10 split
- Total value
- $1.15M
- −$1.36M (−54.2%) vs. Q2 2022
- New holders
- 3
- 9 more added
- Sold out
- 10
- 8 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TOVX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $495.5K |
| Q1 2026 | 22 | $385.4K |
| Q4 2025 | 21 | $272.4K |
| Q3 2025 | 20 | $177.0K |
| Q2 2025 | 17 | $126.3K |
| Q1 2025 | 11 | $209.8K |
| Q4 2024 | 10 | $60.3K |
| Q3 2024 | 18 | $678.6K |
| Q2 2024 | 22 | $327.6K |
| Q1 2024 | 24 | $366.3K |
| Q4 2023 | 24 | $452.3K |
| Q3 2023 | 21 | $572.8K |
| Q2 2023 | 18 | $1.01M |
| Q1 2023 | 19 | $724.6K |
| Q4 2022 | 22 | $477.1K |
| Q3 2022 | 26 | $1.15M |
| Q2 2022 | 33 | $2.51M |
| Q1 2022 | 35 | $3.17M |
| Q4 2021 | 35 | $3.24M |
| Q3 2021 | 36 | $3.32M |
| Q2 2021 | 31 | $3.91M |
| Q1 2021 | 32 | $5.80M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Theriva Biologics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 525,085 | $518.0K | 0.00% | −4,565−0.9% | ReducedConverted for a 1-for-10 split |
| BlackRock Inc. | 190,169 | $187.0K | 0.00% | +1,600+0.8% | AddedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 116,581 | $114.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Citadel Advisors LLC | 56,077 | $55.0K | 0.00% | +56,077 | New |
| State Street Corp | 48,691 | $48.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Northern Trust Corp | 35,699 | $35.0K | 0.00% | +2,620+7.9% | AddedConverted for a 1-for-10 split |
| Blair William & Co | 31,704 | $31.0K | 0.00% | +1,389+4.6% | AddedConverted for a 1-for-10 split |
| Renaissance Technologies LLC | 31,710 | $31.0K | 0.00% | +9,810+44.8% | AddedConverted for a 1-for-10 split |
| Bridgeway Capital Management, LLC | 28,528 | $28.0K | 0.00% | +28,528 | New |
| Two Sigma Securities, LLC | 18,352 | $18.0K | 0.00% | +11,368+162.8% | AddedConverted for a 1-for-10 split |
| Susquehanna International Group, LLP | 16,408 | $16.0K | 0.00% | +12,474+317.0% | AddedConverted for a 1-for-10 split |
| Charles Schwab Investment Management Inc | 13,567 | $14.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| IFP Advisors, Inc | 3,825 | $13.0K | 0.00% | +3,443+900.0% | AddedConverted for a 1-for-10 split |
| Two Sigma Advisers, LP | 12,390 | $12.0K | 0.00% | −1,140−8.4% | ReducedConverted for a 1-for-10 split |
| Fisher Asset Management, LLC | 12,569 | $12.0K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Virtu Financial LLC | 12,447 | $12.0K | 0.00% | +12,447 | New |
| UBS Group AG | 6,766 | $7.00K | 0.00% | +6,357+1,554.7% | AddedConverted for a 1-for-10 split |
| Tower Research Capital LLC (TRC) | 366 | $0 | 0.00% | −732−66.7% | ReducedConverted for a 1-for-10 split |
| Morgan Stanley | 298 | $0 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Bank of America Corp | 6 | $0 | 0.00% | +0+3.4% | AddedConverted for a 1-for-10 split |
| Wells Fargo & Company | 105 | $0 | 0.00% | −1−0.9% | ReducedConverted for a 1-for-10 split |
| Royal Bank of Canada | 7 | $0 | 0.00% | −0−2.8% | ReducedConverted for a 1-for-10 split |
| Focused Wealth Management, Inc | 50 | $0 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Advisor Group Holdings, Inc. | 47 | $0 | 0.00% | −1−1.9% | ReducedConverted for a 1-for-10 split |
| Steward Partners Investment Advisory, LLC | 14 | $0 | 0.00% | −0−2.1% | ReducedConverted for a 1-for-10 split |
| Rockefeller Capital Management L.P. | 26 | $0 | 0.00% | −0−0.8% | ReducedConverted for a 1-for-10 split |
| Truist Financial Corp | 0 | $0 | 0.00% | −120,003−100.0% | Sold outConverted for a 1-for-10 split |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −16,137−100.0% | Sold outConverted for a 1-for-10 split |
| MSD Partners, L.P. | 0 | $0 | 0.00% | −11,643−100.0% | Sold outConverted for a 1-for-10 split |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −2,204−100.0% | Sold outConverted for a 1-for-10 split |
| Landmark Financial Advisors, LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold outConverted for a 1-for-10 split |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −1,850−100.0% | Sold outConverted for a 1-for-10 split |
| 1620 Investment Advisors, Inc. | 0 | $0 | 0.00% | −1,500−100.0% | Sold outConverted for a 1-for-10 split |
| Creative Planning | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| FMR LLC | 0 | $0 | 0.00% | −110−100.0% | Sold outConverted for a 1-for-10 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-10 split |